Protagonist Therapeutics
PTGX
PTGX
40 hedge funds and large institutions have $103M invested in Protagonist Therapeutics in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+2
Holders Change %
+5.26%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
7
Increased
11
Reduced
15
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$4.43M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
$21.2M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
$320K |
| 4 |
PP
PDT Partners
New York
|
$231K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
$32.3M |
